DE69306379D1 - Inhalierbare arzneimittel - Google Patents

Inhalierbare arzneimittel

Info

Publication number
DE69306379D1
DE69306379D1 DE69306379T DE69306379T DE69306379D1 DE 69306379 D1 DE69306379 D1 DE 69306379D1 DE 69306379 T DE69306379 T DE 69306379T DE 69306379 T DE69306379 T DE 69306379T DE 69306379 D1 DE69306379 D1 DE 69306379D1
Authority
DE
Germany
Prior art keywords
pct
composition
sec
medicament
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69306379T
Other languages
English (en)
Other versions
DE69306379T2 (de
Inventor
Lewis James Baskeyfield
Graham Frederick Jay
Paul Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929205183A external-priority patent/GB9205183D0/en
Priority claimed from GB929205738A external-priority patent/GB9205738D0/en
Priority claimed from GB929205739A external-priority patent/GB9205739D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DE69306379D1 publication Critical patent/DE69306379D1/de
Application granted granted Critical
Publication of DE69306379T2 publication Critical patent/DE69306379T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69306379T 1992-03-10 1993-03-10 Inhalierbare arzneimittel Expired - Lifetime DE69306379T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929205183A GB9205183D0 (en) 1992-03-10 1992-03-10 Formulation
GB929205738A GB9205738D0 (en) 1992-03-17 1992-03-17 Formulations
GB929205739A GB9205739D0 (en) 1992-03-17 1992-03-17 Formulations
PCT/GB1993/000503 WO1993017663A1 (en) 1992-03-10 1993-03-10 Pharmaceutical inhalation compositions

Publications (2)

Publication Number Publication Date
DE69306379D1 true DE69306379D1 (de) 1997-01-16
DE69306379T2 DE69306379T2 (de) 1997-06-12

Family

ID=27266086

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69306379T Expired - Lifetime DE69306379T2 (de) 1992-03-10 1993-03-10 Inhalierbare arzneimittel

Country Status (12)

Country Link
US (1) US5607662A (de)
EP (1) EP0630230B1 (de)
JP (1) JP2736168B2 (de)
AT (1) ATE145819T1 (de)
CA (1) CA2131285C (de)
DE (1) DE69306379T2 (de)
DK (1) DK0630230T3 (de)
ES (1) ES2099428T3 (de)
FI (1) FI110162B (de)
GR (1) GR3022527T3 (de)
NO (1) NO307203B1 (de)
WO (1) WO1993017663A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6192882B1 (en) * 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US6197280B1 (en) 1997-09-09 2001-03-06 Bioglan Laboratories Limited Pharmaceutical compositions and devices for their administration
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
HUP0004821A2 (hu) * 1997-12-03 2001-06-28 Fujisawa Pharmaceutical Co., Ltd. Lágy pellet alakjában lévő gyógyszerkészítmény és előállítása
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
WO2001026630A1 (fr) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Preparations pour inhalation en poudre et leur procede de production
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1458360B1 (de) 2001-12-19 2011-05-11 Novartis AG Pulmonale verabreichung von aminoglykosiden
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
JP2006087815A (ja) * 2004-09-27 2006-04-06 Canon Inc 噴霧方法および該方法に基づく噴霧装置
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
JP2011503113A (ja) 2007-11-13 2011-01-27 メリテイジ ファーマ，インク． 胃腸炎の治療用組成物
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
RU2770039C2 (ru) * 2017-03-07 2022-04-14 Филип Моррис Продактс С.А. Вдыхаемые составы на основе никотина и способы их получения и применения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB8820398D0 (en) * 1988-08-27 1988-09-28 Fisons Plc Pharmaceutical formulation
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers

Also Published As

Publication number Publication date
US5607662A (en) 1997-03-04
CA2131285C (en) 2004-06-29
GR3022527T3 (en) 1997-05-31
FI944123A0 (fi) 1994-09-08
FI944123A (fi) 1994-09-08
ES2099428T3 (es) 1997-05-16
JP2736168B2 (ja) 1998-04-02
WO1993017663A1 (en) 1993-09-16
EP0630230A1 (de) 1994-12-28
FI110162B (fi) 2002-12-13
DK0630230T3 (da) 1997-06-02
JPH07504432A (ja) 1995-05-18
NO943241L (no) 1994-09-01
ATE145819T1 (de) 1996-12-15
CA2131285A1 (en) 1993-09-16
NO307203B1 (no) 2000-02-28
NO943241D0 (no) 1994-09-01
DE69306379T2 (de) 1997-06-12
EP0630230B1 (de) 1996-12-04

Similar Documents

Publication Publication Date Title
DE69306379D1 (de) Inhalierbare arzneimittel
Sigal et al. Symptomatic benign migratory glossitis: report of two cases and literature review
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
DE69633721D1 (de) Verabreichung von arzneistoffen im unteren verdauungstrakt
MY115688A (en) Pharmaceutical composition for administration by inhalation
EE03221B1 (et) Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks
ATE261301T1 (de) Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel
ATE222495T1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
HUP0102892A2 (hu) Erősen tömörített szilárd gyógyszerkészletet tartalmazó hatóanyag-leadó rendszer, eljárás az előállítására és alkalmazására
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
JPH072654A (ja) 吸入によるタウリン投与装置
DE69832070D1 (de) Eine Verpackungseinheit für die Medikamentverabreichung in der olfaktorischen Region
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
ATE213626T1 (de) Feste, therapeutische oder hygienische, mucoadhäsive zusammensetzung zur verabreichung durch auftragen auf der mund-schleimhaut oder der nasen-schleimhaut
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
IL112288A (en) Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases
CA2419077A1 (en) A method of treating a systemic disease
Williams et al. The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
EP0397211A3 (de) Perkutane Verabreichung von 3'-Azido-3'-Deoxythymidin
JPH0967256A (ja) 感冒薬
JP2006508993A5 (de)
JPH0251405B2 (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition